Fund One Welcomes Centese to Portfolio
Evan Luxon is a rare founder, particularly for the Nebraska startup ecosystem. One might say that his entire career pointed him to leading Centese.
As a proud graduate of Omaha North, Evan went on to earn his undergraduate degree in mechanical engineering at the University of Nebraska-Lincoln. However, he didn't stop there. Next, he earned a bioengineering and innovation degree from Johns Hopkins University. Evan capped all this expertise in engineering and the healthcare industry off with a Master's from Stanford, where he focused on medical device design and entrepreneurship.
After his time at Stanford, Evan started working for a medical device incubator. It was here that the idea for Centese was born!
Centese is transforming surgical drainage for cardiothoracic surgeries by developing technology that improves outcomes and reduces costs associated with the recovery process. Patient outcomes following cardiothoracic surgery hinge on proper chest tube drainage and the accuracy of measurements related to patient recovery. Current surgical drainage systems remain unreliable and often result in complications. Centese provides an intelligent surgical drainage system improving patient outcomes, reducing costs, and providing a better patient experience.
“Unfortunately, the devices that they use today are very archaic,” Evan explained, “What we have done at Centese is taken technology and applied it to that portion of the patient recovery”.
Centese is a surgeon's choice for post-operative surgical drainage and is currently being used in marquee healthcare systems like Mayo Clinic, NYU, Stanford and more. Healthcare teams using the device share that it helps:
Patients recover more quickly
Provide clinicians with reliable data to make more informed decisions
ICU and critical care teams streamline labor-intensive workflow
“Evan is as visionary as he is responsible,” shared Erica Wassinger, general partner at Proven Ventures, “He’s the type of talent we hope to partner with over and over again with our fund!”
Hear more of Evan’s founding story: